- Home
- AQST vs AMCX Comparison
AQST vs AMCX Comparison
Compare AQST & AMCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- AMCX
- Stock Information
- Founded
- AQST 2004
- AMCX 1980
- Country
- AQST United States
- AMCX United States
- Employees
- AQST N/A
- AMCX N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- AMCX Cable & Other Pay Television Services
- Sector
- AQST Health Care
- AMCX Telecommunications
- Exchange
- AQST Nasdaq
- AMCX Nasdaq
- Market Cap
- AQST 272.9M
- AMCX 287.1M
- IPO Year
- AQST 2018
- AMCX 2011
- Fundamental
- Price
- AQST $2.71
- AMCX $6.61
- Analyst Decision
- AQST Strong Buy
- AMCX Sell
- Analyst Count
- AQST 5
- AMCX 5
- Target Price
- AQST $11.40
- AMCX $6.50
- AVG Volume (30 Days)
- AQST 1.7M
- AMCX 645.0K
- Earning Date
- AQST 05-12-2025
- AMCX 05-09-2025
- Dividend Yield
- AQST N/A
- AMCX N/A
- EPS Growth
- AQST N/A
- AMCX N/A
- EPS
- AQST N/A
- AMCX N/A
- Revenue
- AQST $54,228,000.00
- AMCX $2,380,086,000.00
- Revenue This Year
- AQST N/A
- AMCX N/A
- Revenue Next Year
- AQST $40.62
- AMCX N/A
- P/E Ratio
- AQST N/A
- AMCX N/A
- Revenue Growth
- AQST 5.29
- AMCX N/A
- 52 Week Low
- AQST $2.12
- AMCX $5.41
- 52 Week High
- AQST $5.80
- AMCX $18.58
- Technical
- Relative Strength Index (RSI)
- AQST 54.01
- AMCX 55.24
- Support Level
- AQST $2.22
- AMCX $6.39
- Resistance Level
- AQST $2.79
- AMCX $6.73
- Average True Range (ATR)
- AQST 0.19
- AMCX 0.35
- MACD
- AQST 0.04
- AMCX 0.06
- Stochastic Oscillator
- AQST 75.64
- AMCX 88.24
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About AMCX AMC Networks Inc.
AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.